These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36892313)

  • 21. Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response.
    Derosa S; Misztak P; Mingardi J; Mazzini G; Müller HK; Musazzi L
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110871. PubMed ID: 37793481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal prolactin levels in rat plasma correlates with response to antidepressant treatment in animal model of depression.
    Faron-Górecka A; Kuśmider M; Szafran-Pilch K; Kolasa M; Żurawek D; Gruca P; Papp M; Solich J; Pabian P; Dziedzicka-Wasylewska M
    Neurosci Lett; 2017 Apr; 647():147-152. PubMed ID: 28336340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic oral ketamine prevents anhedonia and alters neuronal activation in the lateral habenula and nucleus accumbens in rats under chronic unpredictable mild stress.
    Kingir E; Sevinc C; Unal G
    Neuropharmacology; 2023 May; 228():109468. PubMed ID: 36813161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.
    Ma XC; Dang YH; Jia M; Ma R; Wang F; Wu J; Gao CG; Hashimoto K
    PLoS One; 2013; 8(2):e56053. PubMed ID: 23390559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats.
    Fu W; Xie H; Laudon M; Zhou S; Tian S; You Y
    Psychopharmacology (Berl); 2016 Jun; 233(12):2229-39. PubMed ID: 27007604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats.
    Papp M; Vassout A; Gentsch C
    Behav Brain Res; 2000 Oct; 115(1):19-23. PubMed ID: 10996404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesolimbic dopamine system and its modulation by vitamin D in a chronic mild stress model of depression in the rat.
    Sedaghat K; Yousefian Z; Vafaei AA; Rashidy-Pour A; Parsaei H; Khaleghian A; Choobdar S
    Behav Brain Res; 2019 Jan; 356():156-169. PubMed ID: 30144460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant effects of ketamine on depression-related phenotypes and dopamine dysfunction in rodent models of stress.
    Rincón-Cortés M; Grace AA
    Behav Brain Res; 2020 Feb; 379():112367. PubMed ID: 31739001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine.
    Mingardi J; Ndoj E; Bonifacino T; Misztak P; Bertoli M; La Via L; Torazza C; Russo I; Milanese M; Bonanno G; Popoli M; Barbon A; Musazzi L
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression.
    Jayatissa MN; Bisgaard C; Tingström A; Papp M; Wiborg O
    Neuropsychopharmacology; 2006 Nov; 31(11):2395-404. PubMed ID: 16482085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspectives for therapy of treatment-resistant depression.
    Papp M; Cubala WJ; Swiecicki L; Newman-Tancredi A; Willner P
    Br J Pharmacol; 2022 Sep; 179(17):4181-4200. PubMed ID: 34128229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Wistar-Kyoto rat model of depression and the role of synaptic plasticity in depression and antidepressant response.
    Aleksandrova LR; Wang YT; Phillips AG
    Neurosci Biobehav Rev; 2019 Oct; 105():1-23. PubMed ID: 31336112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression.
    Rossetti AC; Paladini MS; Brüning CA; Spero V; Cattaneo MG; Racagni G; Papp M; Riva MA; Molteni R
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.
    Franceschelli A; Sens J; Herchick S; Thelen C; Pitychoutis PM
    Neuroscience; 2015 Apr; 290():49-60. PubMed ID: 25595985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine supresses REM sleep and markedly increases EEG gamma oscillations in the Wistar Kyoto rat model of treatment-resistant depression.
    Kantor S; Lanigan M; Giggins L; Lione L; Magomedova L; de Lannoy I; Upton N; Duxon M
    Behav Brain Res; 2023 Jul; 449():114473. PubMed ID: 37146722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fast-onset effects of Pseudospondias microcarpa (A. Rich) Engl. (Anacardiaceae) hydroethanolic leaf extract on behavioral alterations induced by chronic mild stress in mice.
    Adongo DW; Mante PK; Kukuia KKE; Benneh CK; Biney RP; Boakye-Gyasi E; Amekyeh H; Harley BK; Tandoh A; Okyere PD; Woode E
    PLoS One; 2023; 18(2):e0278231. PubMed ID: 36730151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives.
    Strekalova T; Liu Y; Kiselev D; Khairuddin S; Chiu JLY; Lam J; Chan YS; Pavlov D; Proshin A; Lesch KP; Anthony DC; Lim LW
    Psychopharmacology (Berl); 2022 Mar; 239(3):663-693. PubMed ID: 35072761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression.
    Price JB; Yates CG; Morath BA; Van De Wakker SK; Yates NJ; Butters K; Frye MA; McGee SL; Tye SJ
    Transl Psychiatry; 2021 Nov; 11(1):598. PubMed ID: 34824208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.
    Duda W; Curzytek K; Kubera M; Connor TJ; Fagan EM; Basta-Kaim A; Trojan E; Papp M; Gruca P; Budziszewska B; Leśkiewicz M; Maes M; Lasoń W
    Int Immunopharmacol; 2019 Aug; 73():527-538. PubMed ID: 31176083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.